Tag: estrogen
-
FDA Ditching Black Box Warnings on Low-Dose Estrogen: What It Means for Menopause Care
What Changed and Why It Matters The U.S. Food and Drug Administration (FDA) has announced a significant regulatory change: it will no longer require the strongest safety notice, the black box warning, on prescription, low-dose estrogen products used to treat perimenopause and menopause. This shift follows a nuanced assessment of the risks and benefits of…
-
FDA Lifts Black Box Warning on Low-Dose Estrogen: What It Means for Menopause Care
Overview: A Shift in Menopause Care The U.S. Food and Drug Administration has announced a notable change in how low-dose estrogen products used to treat perimenopause and menopause are labeled. By removing the mandatory black box warnings—the most prominent safety alerts—the agency signals a move toward more nuanced, individualized discussions between patients and clinicians about…
-
6 Questions to Ask About Hormone Therapy for Menopause
Understanding Hormone Therapy in Menopause For many women, menopause brings hot flashes, night sweats, sleep disruption, and mood changes. Hormone therapy (HT) is a treatment option that can alleviate these symptoms and improve quality of life. Recent updates from health authorities have spotlighted the safety profile of estrogen-based hormone therapy, including changes to labeling that…
-
Ireland study suggests HRT after menopause may lower dementia risk for women
New Irish findings connect lifetime oestrogen exposure and dementia risk A new study from Ireland suggests that women who maintain higher exposure to oestrogen across their lives—and those who use hormone replacement therapy (HRT) after menopause—may face a lower risk of developing dementia. Led by Dr Emer McGrath, an associate professor of medicine at the…
-
Women and Menopause: Could HRT After Menopause Lower Dementia Risk, Irish Study Suggests
New insights on estrogen, cognition, and dementia risk Autsome women’s health research in Ireland is shedding light on how lifetime exposure to oestrogen might influence brain aging. An Irish study from the University of Galway, led by Dr. Emer McGrath, analyzed reproductive and hormonal factors across a woman’s life to uncover connections with cognitive outcomes…
-
HRT After Menopause Linked to Lower Dementia Risk in Irish Study
Overview A new Irish study suggests that women who take hormone replacement therapy (HRT) after menopause may have a reduced risk of developing dementia. The research, led by University of Galway associate professor Dr. Emer McGrath, examined how lifetime exposure to oestrogen from various sources could influence brain aging and cognitive function. What the study…
-
Obesity and Cancer: How Bariatric Surgery Reduces Risk Across 12 Cancers in India
Obesity and cancer: a rising link in India Obesity has become a public health crisis in India, affecting both urban and rural populations. Beyond well-known risks like diabetes and heart disease, excess body weight is now linked to an increased risk of at least 12 different cancers. The IARC’s findings, which point to obesity as…
-
Intestinal Health and Menopause: A National Study Aims to Uncover the Hidden Health Axis
Introduction: A National Effort to Map the Hidden Health Axis A pioneering national study in Portugal is underway to explore the so called invisible axis between intestinal microbiota and hormonal changes during perimenopause and menopause. The goal is to prevent chronic symptoms and improve the health trajectory of women through midlife and beyond. Led by…
-
Intestinal Health and Menopause: The Hidden Axis of Women’s Health
Intestinal health and menopause: uncovering an invisible axis Recent surveys show that almost 60% of women report that menopausal symptoms negatively affect their daily lives, including family and sexual relationships. In Portugal, a national study led by the Gulbenkian Institute of Molecular Medicine (GIMM) aims to go deeper: to explore the so‑called invisible axis of…